Factor VIII genotype and the risk of developing highresponding or low-responding inhibitors in severe hemophilia A: data from the PedNet Hemophilia Cohort of 1,202 children.

Andersson, Nadine G; Labarque, Veerle; Kartal-Kaess, Mutlu; Pinto, Fernando; Mikkelsen, Torben Stamm; Ljung, Rolf; Group, PedNet Study

Andersson, Nadine G; Labarque, Veerle; Kartal-Kaess, Mutlu; Pinto, Fernando; Mikkelsen, Torben Stamm; Ljung, Rolf; Group, PedNet Study.

Affiliation

Andersson NG; Center for Thrombosis and Hemostasis, Skåne University Hospital, Malmö, Sweden; Department of Pediatrics, Skåne University Hospital, Lund, Sweden; Department of Clinical Sciences and Pediatrics, Lund University, Lund. nadine.gretenkort_andersson@med.lu.se.
Labarque V; Department of Pediatrics, Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium.
Kartal-Kaess M; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Inselspital, University Hospital, University of Bern, Bern.
Pinto F; Royal Hospital for Children, Glasgow, UK.
Mikkelsen TS; Department of Pediatric Oncology and Hematology, University Hospital, Aarhus, Denmark.
Ljung R; Department of Pediatrics, Skåne University Hospital, Lund.
Group PS; PedNet group, Table S1, Supplement.

Haematologica ; 109(4): 1293-1296, 2024 Apr 01.

Article in En | MEDLINE | ID: mdl-37881836

Subject(s)

Hemophilia A; Hemostatics; Child; Humans; Hemophilia A/drug therapy; Hemophilia A/genetics; Factor VIII/genetics; Risk Factors; Genotype

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Hemostatics / Hemophilia A Limits: Child / Humans Language: En Year: 2024 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Hemostatics / Hemophilia A Limits: Child / Humans Language: En Year: 2024 Type: Article